Are there different evidence thresholds for genomic vs. clinical precision medicine? A VOI-based framework applied to antiplatelet drug therapy

OBJECTIVE: To evaluate evidence thresholds for clinically-guided precision medicine (PM) vs. genomically-guided PM. METHODS: We develop an “evidence threshold criterion” (ETC) that is the time-weighted difference between expected value of perfect information (EVPI) and incremental net health benefit...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Value Health
Hoofdauteurs: Guzauskas, Gregory F., Basu, Anirban, Serbin, Michael, Carlson, Josh J., Veenstra, David L.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2019
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6746330/
https://ncbi.nlm.nih.gov/pubmed/31511188
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jval.2019.03.023
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items